Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Pediatrix Medical (MD) EPS (Basic) (2016 - 2026)

Pediatrix Medical (MD) has disclosed EPS (Basic) for 17 consecutive years, with $0.41 as the latest value for Q4 2025.

  • Quarterly EPS (Basic) rose 10.81% to $0.41 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $1.97 through Dec 2025, up 265.55% year-over-year, with the annual reading at $1.97 for FY2025, 265.55% up from the prior year.
  • EPS (Basic) for Q4 2025 was $0.41 at Pediatrix Medical, down from $0.85 in the prior quarter.
  • The five-year high for EPS (Basic) was $0.85 in Q3 2025, with the low at -$1.84 in Q2 2024.
  • Average EPS (Basic) over 5 years is $0.12, with a median of $0.32 recorded in 2022.
  • The sharpest move saw EPS (Basic) surged 1300.0% in 2021, then plummeted 641.18% in 2024.
  • Over 5 years, EPS (Basic) stood at $0.56 in 2021, then crashed by 44.64% to $0.31 in 2022, then crashed by 587.1% to -$1.51 in 2023, then skyrocketed by 124.5% to $0.37 in 2024, then rose by 10.81% to $0.41 in 2025.
  • According to Business Quant data, EPS (Basic) over the past three periods came in at $0.41, $0.85, and $0.46 for Q4 2025, Q3 2025, and Q2 2025 respectively.